While BAP1 has been regarded as a tumor suppressor possessing diverse molecular mechanisms [37], we reveal a possibility that BAP1 might serve as a redox regulator to inhibit NRF2 target genes and suppress the growth of lung cancer cells by deubiquitinating KEAP1. The gene discussed is NFE2L2; the disease is lung cancer.